Objectives: The aim of this study is to understand the barriers and resulting solutions encountered by mental health service staff during the implementation of a metabolic risk assessment programme.
Method: Semi-structured qualitative interviews were held with key programme staff. Thematic analysis was performed on the resulting data.
Results: Barriers identified included an existing mindset that care of service users’ physical health is not part of Mental Health Service ‘core business’; the lack of processes that ensure consistent implementation of risk assessment; and lack of resources in terms of equipment and staff time/manpower. Solutions identified were categorized as: systems and process issues; staff training or education issues; issues requiring attention at an organizational level; and issues relating to service users, their family and communities.
Conclusions: A valuable programme that contributes to the improved physical health of service users has been developed and implemented. However, a number of barriers to wider adoption were identified. Solutions to a number of these barriers were identified during implementation.
DunbarLBrandtTWheelerAHarrisonJCondellWStoepkerJ. Implementing metabolic risk assessment in a secondary care mental health service. Australasian Psychiatry2010; 18: 318–321–
2.
BarnesTREPatonCCavanaghMRHancockETaylorDM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin2007; 33: 1397–1403–
3.
HylandBJuddFDavidsonSJolleyDHockingB. Case managers’ attitudes to the physical health of their patients. Australian and New Zealand Journal of Psychiatry2003; 37: 710–714–
4.
DrussBGMarcusSCCampbellJ. Medical services for clients in community mental health centers: results from a national survey. Psychiatric Services2008; 59: 917–920–
5.
WheelerAHarrisonJHomesZ. Cardiovascular risk assessment and management in mental health clients: perceptions of mental health and general practitioners in New Zealand. Journal of Primary Health Care2009; 1: 11–19–
6.
BoardmanJB. Health access and integration for adults with serious and persistent mental illness. Families, Systems & Health: The Journal of Collaborative Family HealthCare2006; 24: 3–18–
7.
MackinPBishopDRWatkinsonHMO. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry2007; 7: 28–
8.
TaylorDYoungCEsopRPatonCWalwynR. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. British Journal of Psychiatry2004; 185: 152–156–
9.
RuncieOBoilsonMHamiltonR. Monitoring weight and blood glucose in in-patients: how helpful is a protocol?Psychiatric Bulletin2007; 31: 88–91–
10.
BarnesTREPatonCHancockECavanaghMRTaylorDLelliottP. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: A quality improvement programme. Acta Psychiatrica Scandinavica2008; 118: 26–33–
11.
NewcomerJWNasrallahHAMcIntyreRSHennekensCHVogel-ScibiliaS. Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. CNS Spectrums2008; 13: 1–14–
12.
WalterGDeLarocheASohN. Side effects of second generation antipsychotics: the experience, views and monitoring practices of Australian child psychiatrists. Australasian Psychiatry2008; 16: 253–262–
13.
NguyenDBrakouliasVBoyceP. An evaluation of monitoring practices in patients on second generation antipsychotics. Australasian Psychiatry2009; 17: 295–299–
